NGM Biopharmaceuticals, Inc.
Methods of using variants of FGF19 polypeptides for the treatment of cancer
Last updated:
Abstract:
Provided are methods of antagonizing the oncogenic activity of FGF19 in a subject. Also provided are methods of treating a FGF19-dependent cancer or tumor, or a symptom thereof in a subject.
Status:
Grant
Type:
Utility
Filling date:
27 Oct 2014
Issue date:
6 Aug 2019